Vaclav Smid

Prague, PR 12108, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis.

Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis.

Journal: Scientific reports

Published: January 08, 2026

Molecular spectroscopy of blood plasma differentiates metabolic dysfunction-associated steatohepatitis from steatosis.

Molecular spectroscopy of blood plasma differentiates metabolic dysfunction-associated steatohepatitis from steatosis.

Journal: Journal of translational medicine

Published: April 12, 2025

The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.

The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.

Journal: International journal of molecular sciences

Published: October 31, 2023

Methaemoglobinaemia and oesophageal burns after accidental ingestion of an alkyl nitrite.

Methaemoglobinaemia and oesophageal burns after accidental ingestion of an alkyl nitrite.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: September 14, 2022

Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension.

Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 19, 2022

Liver tests.

Liver tests.

Journal: Casopis lekaru ceskych

Published: June 21, 2022

Diagnosis of non-alcoholic fatty liver disease and its active screening in risk groups.

Diagnosis of non-alcoholic fatty liver disease and its active screening in risk groups.

Journal: Casopis lekaru ceskych

Published: June 21, 2022

An overview of current therapy options of non-alcoholic fatty liver disease.

An overview of current therapy options of non-alcoholic fatty liver disease.

Journal: Casopis lekaru ceskych

Published: June 21, 2022

Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease.

Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease.

Journal: Antioxidants (Basel, Switzerland)

Published: November 09, 2021

The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease.

The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease.

Journal: Biomolecules

Published: September 27, 2021

Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD.

Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD.

Journal: Hepatology communications

Published: September 02, 2021

Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant.

Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant.

Journal: Scientific reports

Published: August 11, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026